6-(5-((2-(4-Ethylpiperazin-1-yl)-7-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)hexanoic acid

Catalog No. :
ACMLBR001
CAS No. :
618076-77-0
Molecular Formula :
C25H31N5O4S2
Molecular Weight :
529.69

IUPAC Name:(Z)-6-(5-((2-(4-ethylpiperazin-1-yl)-7-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)hexanoic acid

6-(5-((2-(4-Ethylpiperazin-1-yl)-7-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)hexanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(5-((2-(4-Ethylpiperazin-1-yl)-7-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)hexanoic acid
IUPAC Name(Z)-6-(5-((2-(4-ethylpiperazin-1-yl)-7-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)hexanoic acid
Molecular FormulaC25H31N5O4S2
Molecular Weight529.69
SMILESO=C(O)CCCCCN(C/1=O)C(SC1=C/C2=C(N3CCN(CC)CC3)N=C(C=CC(C)=C4)N4C2=O)=S
InChI KeyOHWXCXPIYYSYJB-CYVLTUHYSA-N
SynonymSALOR-INT L430250-1EA;6-((5Z)-5-([2-(4-ETHYL-1-PIPERAZINYL)-7-METHYL-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-3-YL]METHYLENE)-4-OXO-2-THIOXO-1,3-THIAZOLIDIN-3-YL)HEXANOIC ACID
CAS No.618076-77-0

Synthetic Route by SureRoute

1. ACMLBR001 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMLBR001 route product structure diagram
    ACMLBR001618076-77-0
Inquiry

2. ACMLBR001 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLBR001 route product structure diagram
    ACMLBR001618076-77-0
Inquiry

Comments (0)